Asthma Treatment Market to Gain Traction as Sales in Retail Pharmacies Reach US$ 17 Bn

Top Asthma Treatment Market Players to Command Over 60% of Sales

Fact.MR’s latest report on asthma treatment market provides meticulous analysis of market dynamics, current developments, and trending business strategies. The study also provides various growth drivers, restraints, challenges, and opportunities affecting the demand across leading segments including therapeutic category, condition, and distribution channel.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per Fact.MR, the global sales of asthma treatment are expected to reach around US$ 17 Bn through retail pharmacies by the end of 2027. Increasing demand for rescue and controller inhalers to reduce and prevent the symptoms of severe asthma is propelling the demand in asthma treatment market.

With growing incidence of severe asthma, especially in children, has increased the need for long-acting inhalers which reduces the side-effects of steroids. However, advent of alternative therapies such as additional panacea which doesn’t have negative effects such as tremors, dysphonia, etc. might hamper the growth in the market.

On account of this, Fact.MR estimates, the global asthma treatment market will witness sluggish growth at over 2.3% CAGR through 2021 & beyond.

As per World Health Organization, over 461000 people succumbed to asthma in 2020. In order to curb the global burden, government and private healthcare facilities have increased the investment to develop novel therapies for asthma treatment.

For instance, in October 2020, Sanofi announced the positive feedback for its Phase 3 trail. According to the company, Dupixent® (dupilumab) significantly reduced severe asthma attacks in children and is the only biologic to demonstrate improvement in children’s lung function in a randomized Phase 3 trial.

Sample Copy With Impact Analysis Of COVID-19 Of Market Report

https://www.factmr.com/connectus/sample?flag=S&rep_id=4422

Subsequently, rising awareness among millennials and baby boomers across developing nations such as India, China, Brazil, and South Korea, regarding the benefits and effective asthma therapeutics is also accelerating the growth in the market.

Against this backdrop, Asia Pacific is expected to emerge as the most lucrative region in the global asthma treatment market, opines Fact.MR.

“Following the outbreak of the novel COVID-19, consumers are heavily reliant on online shopping channels and retail pharmacies for their convenience. To capitalize on this existing trend, key players are collaborating with retail pharmacies and online shops to increase their sales,” says the Fact.MR analyst.

Key Takeaways from Asthma Treatment Market Survey

  • In terms of distribution channel, hospital pharmacies segment is expected to reach US$10 Bn by the end of 2027
  • Long-term asthma control medications are expected to hold over 59% of global market share outpacing quick relief medications
  • Based on route of administration, sales of inhalers are expected to exceed US$ 14 Bn through 2021 & beyond
  • Oral route of administration is anticipated to emerge as the second-most lucrative segment in the asthma treatment market
  • With strong presence of numerous leading players in the U.S., North America asthma treatment market is expected to hold lion’s share during the forecast period
  • India is expected to spearhead the growth in South Asia asthma treatment market owing to the increasing investment by government and healthcare companies to develop novel therapies to treat asthma

Key Drivers

  • Growing prevalence of asthma coupled with increasing investment by governments to develop advanced novel therapies will boost the market
  • Increasing product launches to reduce the negative and fatal effects of severe asthma by leading players will drive the asthma treatment market.
  • Growing research and development activities to develop advanced oral and inhaled asthma treatment will propel the demand for asthma treatment.

Key Restraints

  • High cost associated with asthma medications coupled with inadequate knowledge regarding the disease in under-developed economies is expected to restrict the growth in asthma treatment market.

To gain in-depth insights on Asthma Treatment Market, request methodology at

https://www.factmr.com/connectus/sample?flag=RM&rep_id=4422

Competitive Landscape

As per Fact.MR, the global asthma treatment market is expected to be consolidated, with leading players accounting for over 60% of global market share. These leading players are extensively investing in research and development activities to develop novel drugs and therapies.

They are also focusing on product launches to enhance their products portfolios and to gain competitive edge in the industry.

For instance,

  • In September 2021, Avillion LLP, a drug development company focused on the co-development and financing of pharmaceutical candidates, announced positive high-level results from the MANDALA and DENALI Phase III trials of PT027 (albuterol/budesonide), at both 180/160mcg and 180/80mcg doses, meeting all primary endpoints with significant benefits in patients with asthma versus individual components albuterol.
  • In February 2021, Tezepelumab, the first biologic to achieve consistent and significant reduction in negative effects of severe asthma by demonstrating statistically significant improvements in every key secondary endpoint compared to placebo, including lung function measurements and asthma control through Phase III trial.

Some of the prominent players operating in the asthma treatment market profiled by Fact.MR are:

  • Mylan N.V.
  • Teva Pharmaceutical Industries
  • AstraZeneca PLC.
  • Sunovion Pharmaceutical, Inc.
  • Boehringer Ingelheim
  • Sanofi
  • F.Hoffmann-La Roche Ltd.
  • Novartis International AG
  • GlaxoSmithKline PLC
  • Merck & Co., Inc.
  • Others

More Insights on the Global Asthma Treatment Sales Outlook

A recent study by Fact.MR on the asthma treatment market offers a 10-year forecast. The study analyzes crucial trends that are currently determining the growth of the asthma treatment market. In order to gain better understanding, the market is segmented on the basis of:

Treatment Type:

  • Long-term Asthma Control Medications
  • Combination Inhalers
  • Inhaled Corticosteroids
  • Long-acting Beta Agonists
  • Leukotriene Modifiers
  • Theophylline
  • Others (reslizumab, benralizumab, etc.)
  • Quick-Relief Medications
  • Short-acting Beta Agonists
  • Ipratropium (Atrovent)
  • Oral & Intravenous Corticosteroids

Route of Administration:

  • Inhaled
  • Oral
  • Intravenous
  • Subcutaneous

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Key Questions Covered in the Asthma Treatment Market Outlook Report

  • The report offers insight into asthma treatment demand outlook for 2021-2031
  • The market study also highlights projected sales growth for asthma treatment market between 2021 and 2031
  • Asthma treatment market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
  • Asthma treatment market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others

Explore Fact.MR’s Coverage on the Healthcare Domain –

Asthma Spacers Market Forecast- Increasing demand for asthma spacers to improve aerosolized medicine administration is likely to propel the market forward throughout the forecast period. Furthermore, several government and healthcare-related programmes to raise awareness about respiratory disorders and associated preventive and therapeutic measures are having a beneficial impact on the demand for spacers. As a result of an enlarged asthma patient pool and highly sophisticated healthcare infrastructure, North America is leading the asthma spacers industry.

Virus induced Asthma Treatment Market Scope - Virus-induced asthma is asthma that develops as a result of a respiratory tract infection. Increased product approvals by the FDA and other regulatory agencies are projected to fuel the virus-induced asthma treatment market. Furthermore, the increased prevalence of asthma, as well as strategic initiatives by market competitors such as collaborations and partnerships, are driving market expansion. The global virus-induced asthma treatment market will also develop due to increased potential for industry participants to expand their geographical presence in growing countries.

Breathalyzer Market Analysis - The need for breathalyzers has been steadily increasing as the number of people abusing alcohol has increased. Various governments have enacted strict legislation to reduce the number of traffic accidents and assure traffic flow, which is likely to increase demand for drug abuse detection breathalyzers, remote breathalyzers, and point-of-care breathalyzers. Alcohol breathalyzers are also used to diagnose asthma, TB, and pylori infection, in addition to detecting alcohol.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.

MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
 

You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.


Contact:

Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
 

Source: Fact.MR

Back to news